Marine College, Shandong University, Weihai, 264209, China.
Marine College, Shandong University, Weihai, 264209, China; Shandong Fu Han Ocean Sci-Tech Co., Ltd, Haiyang, 265100, China.
Microb Pathog. 2022 Jun;167:105559. doi: 10.1016/j.micpath.2022.105559. Epub 2022 May 12.
With the aim to discover novel lactic acid bacteria and Bacillus strains from fish as potential probiotics to replace antibiotics in aquaculture, the present study was conducted to isolate lactic acid bacteria and Bacillus from intestinal tract of healthy crucian carp (Carassiu auratus) and largemouth bass (Micropterus salmoides) and evaluate their resistance against Aeromonas veronii. Based on the evaluation of antibacterial activity and tolerance test, one strain of lactic acid bacteria (Weissella cibaria C-10) and one strain of Bacillus (Bacillus amyloliquefaciens T-5) with strong environmental stability were screened out. The safety evaluation showed that these two strains were non-toxic to crucian carp and were sensitive to most antibiotics. In vivo study, the crucian carps were fed a basal diet supplemented with W. cibaria C-10 (C-10), B. amyloliquefaciens T-5 (T-5) and W. cibaria C-10 + B. amyloliquefaciens T-5 (C-10+T-5), respectively, for 5 weeks. Then, various immune parameters were measured at 35 days of post-feeding. Results showed both probiotics could improve the activities of related immune enzymes, immune factors and non-specific immune antibodies in blood and organs (gill, gut, kidney, liver, and spleen) of crucian carp in varying degrees. Moreover, after 7 days of challenge experiment, the survival rates after challenged with A. veronii of W. cibaria C-10 (C-10), B. amyloliquefaciens T-5 (T-5) and W. cibaria C-10 + B. amyloliquefaciens T-5 (C-10+T-5) supplemented groups to the crucian carps were 20%, 33% and 22%, respectively. Overall, W. cibaria C-10 and B. amyloliquefaciens T-5 could be considered to be developed into microecological preparations for the alternatives of antibiotics in aquaculture.
为了从鱼类中发现新的乳酸菌和芽孢杆菌菌株作为替代水产养殖中抗生素的潜在益生菌,本研究从健康鲫鱼(Carassius auratus)和大口黑鲈(Micropterus salmoides)的肠道中分离乳酸菌和芽孢杆菌,并评估它们对维氏气单胞菌的抗性。基于抗菌活性和耐受力测试的评估,筛选出一株具有强环境稳定性的乳酸菌(魏斯氏菌 C-10)和一株芽孢杆菌(解淀粉芽孢杆菌 T-5)。安全性评估表明,这两株菌对鲫鱼无毒,且对大多数抗生素敏感。体内研究中,鲫鱼分别投喂基础日粮添加魏斯氏菌 C-10(C-10)、解淀粉芽孢杆菌 T-5(T-5)和魏斯氏菌 C-10+解淀粉芽孢杆菌 T-5(C-10+T-5),共 5 周。然后,在投喂后第 35 天测量各种免疫参数。结果表明,两种益生菌均可不同程度地提高鲫鱼血液和器官(鳃、肠、肾、肝和脾)中相关免疫酶、免疫因子和非特异性免疫抗体的活性。此外,攻毒实验 7 天后,经攻毒后鲫鱼的存活率分别为魏斯氏菌 C-10(C-10)、解淀粉芽孢杆菌 T-5(T-5)和魏斯氏菌 C-10+解淀粉芽孢杆菌 T-5(C-10+T-5)添加组的 20%、33%和 22%。总体而言,魏斯氏菌 C-10 和解淀粉芽孢杆菌 T-5 可被开发为水产养殖抗生素替代品的微生态制剂。